Opinion
Video
Overview of the Port Delivery System with Ranibizumab
Author(s):
Margaret Chang, MD, examines the difficulties of frequent anti-VEGF injections and outlines the key aspects of the port delivery system (PDS) for ranibizumab administration.
- Why is sustained delivery of anti-VEGF necessary, and what challenges arise from frequent anti-VEGF injections?
- Can you provide an overview of the port delivery system with ranibizumab?
- How does the device function?
- How is the device implanted?
- How is the device refilled?
- What are the benefits of using the PDS with ranibizumab, and which patients are ideal candidates for this delivery method?
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
